Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2012 May 2;104(9):641-2.
doi: 10.1093/jnci/djs193. Epub 2012 Apr 3.

Unraveling genes, hormones, and breast cancer

Jonine D Figueroa, Louise A Brinton
Editorial

Unraveling genes, hormones, and breast cancer

Jonine D Figueroa et al. J Natl Cancer Inst. .
No abstract available

PubMed Disclaimer

Comment on

  • CYP3A variation, premenopausal estrone levels, and breast cancer risk.
    Johnson N, Walker K, Gibson LJ, Orr N, Folkerd E, Haynes B, Palles C, Coupland B, Schoemaker M, Jones M, Broderick P, Sawyer E, Kerin M, Tomlinson IP, Zvelebil M, Chilcott-Burns S, Tomczyk K, Simpson G, Williamson J, Hillier SG, Ross G, Houlston RS, Swerdlow A, Ashworth A, Dowsett M, Peto J, Dos Santos Silva I, Fletcher O. Johnson N, et al. J Natl Cancer Inst. 2012 May 2;104(9):657-69. doi: 10.1093/jnci/djs156. Epub 2012 Apr 3. J Natl Cancer Inst. 2012. PMID: 22472546 Clinical Trial.

Similar articles

  • CYP3A variation, premenopausal estrone levels, and breast cancer risk.
    Johnson N, Walker K, Gibson LJ, Orr N, Folkerd E, Haynes B, Palles C, Coupland B, Schoemaker M, Jones M, Broderick P, Sawyer E, Kerin M, Tomlinson IP, Zvelebil M, Chilcott-Burns S, Tomczyk K, Simpson G, Williamson J, Hillier SG, Ross G, Houlston RS, Swerdlow A, Ashworth A, Dowsett M, Peto J, Dos Santos Silva I, Fletcher O. Johnson N, et al. J Natl Cancer Inst. 2012 May 2;104(9):657-69. doi: 10.1093/jnci/djs156. Epub 2012 Apr 3. J Natl Cancer Inst. 2012. PMID: 22472546 Clinical Trial.
  • CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.
    Johnson N, Maguire S, Morra A, Kapoor PM, Tomczyk K, Jones ME, Schoemaker MJ, Gilham C, Bolla MK, Wang Q, Dennis J, Ahearn TU, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Augustinsson A, Baynes C, Freeman LEB, Beckmann MW, Benitez J, Bermisheva M, Blomqvist C, Boeckx B, Bogdanova NV, Bojesen SE, Brauch H, Brenner H, Burwinkel B, Campa D, Canzian F, Castelao JE, Chanock SJ, Chenevix-Trench G, Clarke CL; NBCS Collaborators; Conroy DM, Couch FJ, Cox A, Cross SS, Czene K, Dörk T, Eliassen AH, Engel C, Evans DG, Fasching PA, Figueroa J, Floris G, Flyger H, Gago-Dominguez M, Gapstur SM, García-Closas M, Gaudet MM, Giles GG, Goldberg MS, González-Neira A; AOCS Group; Guénel P, Hahnen E, Haiman CA, Håkansson N, Hall P, Hamann U, Harrington PA, Hart SN, Hooning MJ, Hopper JL, Howell A, Hunter DJ; ABCTB Investigators; kConFab Investigators; Jager A, Jakubowska A, John EM, Kaaks R, Keeman R, Khusnutdinova E, Kitahara CM, Kosma VM, Koutros S, Kraft P, Kristensen VN, Kurian AW, Lambrechts D, Le Marchand L, Linet M, Lubiński J, Mannermaa A, Manoukian S, Margolin S, Martens JWM, Mavroudis D, Mayes R, Meindl A, Milne RL, Neuhausen SL, Nevanlinna H, Newman WG, Nielsen SF, Nor… See abstract for full author list ➔ Johnson N, et al. Br J Cancer. 2021 Feb;124(4):842-854. doi: 10.1038/s41416-020-01185-w. Epub 2021 Jan 26. Br J Cancer. 2021. PMID: 33495599 Free PMC article.
  • Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer.
    Johnson N, De Ieso P, Migliorini G, Orr N, Broderick P, Catovsky D, Matakidou A, Eisen T, Goldsmith C, Dudbridge F, Peto J, Dos-Santos-Silva I, Ashworth A, Ross G, Houlston RS, Fletcher O. Johnson N, et al. Cancer Res. 2016 Mar 15;76(6):1485-1493. doi: 10.1158/0008-5472.CAN-15-1410. Cancer Res. 2016. PMID: 26964624 Free PMC article.
  • The influence of genetic polymorphisms on the efficacy and side effects of anastrozole in postmenopausal breast cancer patients.
    Abubakar MB, Wei K, Gan SH. Abubakar MB, et al. Pharmacogenet Genomics. 2014 Dec;24(12):575-81. doi: 10.1097/FPC.0000000000000092. Pharmacogenet Genomics. 2014. PMID: 25203739 Review.
  • Genetic variants of sex hormone-binding globulin and their biological consequences.
    Xita N, Tsatsoulis A. Xita N, et al. Mol Cell Endocrinol. 2010 Mar 5;316(1):60-5. doi: 10.1016/j.mce.2009.08.025. Epub 2009 Sep 4. Mol Cell Endocrinol. 2010. PMID: 19733622 Review.
See all similar articles

Cited by

References

    1. Johnson N, Walker K, Gibson LJ, et al. CYP3A variation, premenopausal estrone levels, and breast cancer risk. J Natl Cancer Inst. 2012;104(9):657–669. - PubMed
    1. Rothman N, Garcia-Closas M, Chatterjee N, et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet. 2010;42(11):978–984. - PMC - PubMed
    1. Yu K, Wacholder S, Wheeler W, et al. A flexible bayesian model for studying gene-environment interaction. PLoS Genet. 2012;8(1):e1002482. - PMC - PubMed
    1. Hankinson SE, Colditz GA, Willett WC. Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res. 2004;6(5):213–218. - PMC - PubMed
    1. Key TJ, Appleby PN, Reeves GK, et al. Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer. 2011;105(5):709–722. - PMC - PubMed